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Abstract
We train and validate a semi-supervised, multi-task LSTM
on 57,675 person-weeks of data from off-the-shelf wear-
able heart rate sensors, showing high accuracy at detect-
ing multiple medical conditions, including diabetes (0.8451),
high cholesterol (0.7441), high blood pressure (0.8086), and
sleep apnea (0.8298). We compare two semi-supervised train-
ing methods, semi-supervised sequence learning and heuris-
tic pretraining, and show they outperform hand-engineered
biomarkers from the medical literature. We believe our work
suggests a new approach to patient risk stratification based
on cardiovascular risk scores derived from popular wearables
such as Fitbit, Apple Watch, or Android Wear.
Introduction
In medicine, each label represents a human life at risk —
for example, a person who recently suffered a heart attack
or experienced an abnormal heart rhythm. As a result, even
widely-used predictive models like CHA2DS2-VASc may
be derived from as few as 25 positive labels (Y H Lip et al.
2009). However, popular wearables, such as Fitbit and Apple
Watch, generate trillions of unlabeled sensor data points per
year, including rich signals like resting heart rate and heart
rate variability, which have been shown to correlate with
health conditions as diverse as diabetes, sleep apnea, atrial
fibrillation, heart failure, sudden cardiac death, and irritable
bowel syndrome (Kamath, Watanabe, and Upton 2012).
Using consumer-grade heart rate sensors in a medical
context presents several challenges. First, the sensors them-
selves have significant error (Gillinov 2016). Second, they
vary the rate of measurement to preserve battery life. Third,
since wearables are used in an ambulatory setting, daily ac-
tivities like walking, exercise, stress, consuming alcohol, or
drinking coffee (Figure 1) may confuse simple heuristics.
Deep neural networks (LeCun, Bengio, and Hinton 2015)
have shown high accuracy at pattern recognition from noisy,
complex inputs, including automated detection of diabetic
retinopathy from images (Gulshan et al. 2016), skin cancer
from mobile phone cameras (Esteva et al. 2017), and the
onset of health conditions from electronic medical records
(Razavian, Marcus, and Sontag 2016; Lipton et al. 2015;
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Choi et al. 2016; Che et al. 2015). However, purely super-
vised deep learning requires many labeled examples. No
such database exists for wearable data, and in most hospi-
tal systems, recruiting even a hundred patients into a new
medical study is labor-intensive and expensive.
To solve this, we take a two-pronged approach. First, we
employ a mobile phone application to recruit 14,011 partic-
ipants from across the world, collecting 200 million unla-
beled sensor measurements. Data from these participants is
then used in one of two semi-supervised training procedures.
In semi-supervised sequence learning (Dai and Le 2015), an
LSTM (Hochreiter and Schmidhuber 1997) is pretrained as a
sequence autoencoder; weights from pretraining are used as
initialization for a second supervised phase, making use of
a limited pool of labeled data from participants with known
diagnoses. In heuristic pretraining, the neural network is in-
stead pretrained to compute heart-rate-derived biomarkers
from the medical literature, partially bridging the gap be-
tween feature engineering and deep learning.
The rest of this paper is organized as follows. We first
describe a novel data set derived from 14,011 participants
with wearable heart rate monitors, recruited in partnership
with the Health eHeart Study of the University of Califor-
nia, San Francisco. We then describe DeepHeart, our model
architecture, and the semi-supervised training methods used,
semi-supervised sequence learning and heuristic pretraining.
Then we present experimental results showing that semi-
supervised deep neural networks achieve higher accuracy
in detecting diabetes, sleep apnea, high blood pressure, and
high cholesterol than several strong baselines derived from
biomarkers in the medical literature. We conclude by de-
scribing some of the historical barriers to wide-scale deploy-
ment of artificial intelligence in medicine and how we plan
to address them in future work.
Data and Study Cohort
Electronic medical records contain important discrete
events, such as lab tests and diagnoses, while continuous
wearable data from mobile health platforms, such as Apple
HealthKit or Google Fit, cover the majority of the patient’s
time outside of a medical setting. In order to train a deep
neural network to predict diagnoses given wearable data, we
sought to combine the two data sources.
Figure 1: Examples of wearable heart rate data showing different physiological states: exercise, sleeping, stress, and medical
conditions.
Study Cohort
We recruited 14,011 users of a popular Apple Watch app
into an online, IRB-approved study run in partnership with
the cardiology department of the University of California,
San Francisco (Tison et al. 2017a). Participants completed
a medical history, including previous diagnoses, blood test
results, and medications. A mobile app—Cardiogram—
integrated with HealthKit continuously stored, processed,
and displayed participant heart rate, step count, and other
activity data.
We chose to focus on four highly prevalent but often undi-
agnosed conditions associated with cardiovascular risk: high
cholesterol, hypertension (high blood pressure), sleep apnea,
and diabetes. 45.8% of diabetes cases are undiagnosed (Bea-
gley et al. 2014). Sleep apnea is estimated to affect 22 mil-
lion people in the US alone, over 80% of whom are undi-
agnosed (Young et al. 1997). Together, high blood pressure
and high cholesterol account for 17.3% of global deaths (Al-
wan and others 2011), as they are both major risk factors for
heart attacks.
Table 1: Cohort Statistics
Condition Number of Person- Person-
People Weeks of Weeks of
Training Testing
Data Data
Unlabeled 1,462 10,616 N/A
High Cholesterol 2,331 9,220 3,243
Hypertension 2,230 7,651 2,762
Sleep Apnea 1,016 3,662 1,141
Diabetes 462 1,678 644
Multi-Channel, Multi-Timescale Sensor Data
Consumer wearables produce multiple channels of data—
most commonly, step count measured using a wrist-worn
accelerometer and optical heart rate measured using photo-
plethysmography. For example, the Apple Watch measures
heart rate every five seconds when in workout mode and
roughly every five minutes during other times of the day.
Likewise, step counts are recorded every few minutes while
the user is walking.
We encoded sensor measurements into a tensor Xu,t,c
with indices for the user-week u, timestep t, and input chan-
nel c. Heart rate and step count were encoded as separate
input channels. To accommodate variable timescales, we en-
coded intra-channel time-deltas as a special dt channel:
dttransformed = 0.1log(
dt
5000
) (1)
Without transforming dt, the model does not train due
to the wide spread of values (ranging from 5000 to
28,800,000).
Sequences contained up to 4096 timesteps of sensor data,
and shorter sequences were zero-padded.
Pre-Processing
Each participant was randomly assigned to either the train-
ing, tuning, or testing set. Each participant’s data was then
split into week-long chunks, and any weeks with ≤ 672
heart rate measurements (≤ 8 hours per day of background
measurements) or ≤ 30 minutes of continuous heart rate
recordings were omitted. After filtering, there were 57,675
person-weeks of data in total, divided into 33,628 for train-
ing, 18,555 for tuning, and 12,790 for validation. The train-
ing, tuning, and testing sets contained completely disjoint
sets of participants.
Figure 2: DeepHeart architecture.
Multi-Task Labeled Output
Similar to X, our output is a tensor Yu,t,c with indices for
the user-week u, timestep t, and output channel c. There are
separate output channels for prevalent cases of each condi-
tion: high cholesterol, hypertension, sleep apnea, and dia-
betes. Diagnoses are derived from validated health surveys
collected in partnership with the Health eHeart Study of the
University of California, San Francisco. In addition, we in-
cluded an output channel of ECG readings1. ECG readings
were aligned to the closest sensor measurement in X, and di-
agnoses were aligned to the last timestep in X. Each Yt[task]
is a discrete label: either positive (user has condition, or ab-
normal ECG reading) or negative (user is not diagnosed with
condition, or ECG reading is normal). We used output mask-
ing to score the models only when Yt[task] has a value.
Model Architecture
Figure 2 shows our model architecture. The inputs are multi-
channel, multi-timescale sensor measurements, and the out-
puts are multi-task, multi-timescale diagnoses. Table 3 sum-
marizes hyperparameter tuning experiments.
Temporal Convolutions
The first three layers are temporal convolutions, which have
been shown to efficiently extract features and model tem-
poral translation invariance (Amodei et al. 2016). The first
layer has a wide filter length of 12, similar to AlexNet
(Krizhevsky, Sutskever, and Hinton 2012), and the next two
layers use the residual units (He et al. 2016) with a filter
1Our research builds on previous work to detect atrial fibrilla-
tion using ECGs. We chose to keep this output task so our model
could benefit from ECG readings.
length of 5. Each convolutional layer contains 128 convo-
lutional channels. After each convolutional layer, we apply
dropout with probability 0.2 to prevent overfitting, and apply
max pooling with pool length 2 to reduce dimensionality.
Bidirectional LSTM
The convolutional layers are followed by four bidirectional
LSTM layers that model longer temporal patterns in wear-
able sensor data and their corresponding multi-timescale di-
agnoses. Each bidirectional LSTM layer contains 128 units
(64 in each direction).
A dropout of 0.2 is applied to this final LSTM layer, and
the result is run through a simple output unit: a convolution
of filter length 1. The purpose of this convolution is to map
the outputs of the LSTM into a single prediction per task,
per timestep. For this final layer, we use a tanh activation so
outputs range from -1 to 1.
Training Methods
In addition to ordinary supervised training, we experimented
with two pretraining architectures. Semi-supervised training
is advantageous here because unlabeled data from wearables
is abundant, but medical condition labels are more scarce.
Unsupervised Sequence Pretraining
Semi-supervised sequence learning has been shown to im-
prove performance when presented with large amounts of
unlabeled training data (Dai and Le 2015). We experimented
with this approach by first training a sequence-to-sequence
autoencoder, consisting of the 3 convolutional and 4 recur-
rent layers. We then use the weights from the autoencoder
as initializing parameters for the corresponding layers in the
supervised architecture. In order to force the autoencoder to
not merely memorize the input, we added Gaussian noise to
the input sequence.
Weakly-Supervised Heuristic Pretraining
Previous work has applied statistical methods on beat-to-
beat variability to detect heart arrhythmias (McManus et al.
2013). Inspired by this, we synthesized a dataset for pretrain-
ing using a time-windowed heart rate variability metric. We
defined four output tasks, with window sizes of 5 seconds,
30 seconds, 5 minutes, and 30 minutes, computed the aver-
age absolute difference between successive heart rate mea-
surements, and used these as output channels in a weakly-
supervised pretraining phase. The resulting weights were
used for initialization in supervised training. In this way, we
use pretraining as a technique to bridge feature engineering
and deep learning.
Experiments
To evaluate our architecture, we ran a series of experiments
summarized in Table 2. For each condition on our data set,
we report the c-statistic—the area under the ROC curve—
on the test set. Each experiment used the Adam optimizer
(Kingma and Ba 2014) and a squared error loss, since we
found squared error to be more numerically stable than
cross-entropy.
Table 2: Experiment Results (c-statistics)
Name Diabetes High Cholesterol Sleep Apnea High Blood Pressure
Logistic Regression 0.7906 0.5941 0.6583 0.6389
Support Vector Machine 0.5722 0.5996 0.5490 0.6106
Decision Tree 0.4142 0.5152 0.6415 0.6625
Random Forest 0.5515 0.5647 0.5907 0.6310
Multi-layer Perceptron 0.7846 0.4327 0.6172 0.7195
LSTM, No Pretraining 0.8451 0.6736 0.8041 0.7991
LSTM, Heuristic Pretraining 0.8366 0.7148 0.7951 0.7427
LSTM, Unsupervised Pretraining 0.7998 0.7441 0.8298 0.8086
Baselines
We compared our architecture with multiple machine learn-
ing algorithms using hand-engineered biomarkers derived
from the medical literature, including resting heart rate (Fox
et al. 2007), time-windowed average heart rate (Kamath,
Watanabe, and Upton 2012), time-windowed standard de-
viation of heart rates (Kamath, Watanabe, and Upton 2012),
time-windowed spectrum entropy (Kamath, Watanabe, and
Upton 2012), time-windowed root mean squared of succes-
sive beats per minute differences (McManus et al. 2013),
and time-windowed entropy of BPM differences (McManus
et al. 2013). We used 5-minute and 30-minute time windows,
and included global versions of standard deviation and RMS
of successive BPM differences, for 13 features in total. We
trained several standard machine learning algorithms on all
of these features, including scikit-learn’s (Pedregosa et al.
2011) implementation of logistic regression, support vec-
tor machines, decision trees, random forests, and multi-layer
perceptrons.
LSTM without Pretraining
We first trained a purely-supervised LSTM without pretrain-
ing, which performed significantly better than the baselines
on sleep apnea (0.80 vs 0.55-0.66), hypertension (0.80 vs
0.61-0.72), high cholesterol (0.67 vs 0.43-0.60), and dia-
betes (0.85 vs 0.41-0.79). The gap is smallest for diabetes,
with the least amount of labeled data, suggesting poten-
tial benefit from combining hand-engineered features with
deep learning. Previous work from the medical community
has suggested that diabetes may impact heart rate variability
through effects on the autonomic nervous system (Kudat et
al. 2006). Our work builds on top of these previous findings,
and suggests that heart rate variability changes driven by di-
abetes can be detected via consumer, off-the-self wearable
heart rate sensors.
Heuristic Pretrained LSTM
When the supervised LSTM is initialized with weights from
heuristic pretraining, we saw noticeable improvements for
high cholesterol (0.71 vs 0.67), neutral results for sleep ap-
nea and diabetes, and a significant loss for high blood pres-
sure (0.74 vs 0.80). The gain on high cholesterol is partic-
ularly surprising, given that the baseline results, which are
based on similar hand-engineered heuristic features, did not
perform well. One explanation is that the neural network is
able to find non-linear relationships for the underlying pat-
terns that generate these heuristic features, and the insights
discovered by the heuristic pretraining were useful for pre-
dicting high cholesterol.
On high blood pressure, the heuristic-pretrained LSTM
performs significantly worse than the LSTM without pre-
training. One explanation is that the heuristic of average
BPM differences is a poor predictor of high blood pres-
sure, and gradient descent cannot escape from this space of
poorly-performing predictors.
Semi-supervised Sequence Learning
The last experiment applied semi-supervised sequence
learning: we first pretrained DeepHeart as a sequence au-
toencoder, using the encoder weights as initialization for a
second, supervised phase, as described in (Dai and Le 2015).
This approach resulted in a significant improvement on high
cholesterol, high blood pressure, and sleep apnea.
The 0.83 c-statistic at detecting sleep apnea is surprising
given that few participants sleep with their watch. This sug-
gests that wearable-derived biomarkers measured during the
day capture a distinct signature of sleep apnea.
Among all four health conditions, high cholesterol has the
least direct physiological relationship with heart rate vari-
ability in the medical literature. While we are able to detect
high cholesterol with c-statistic of 0.74, it is the lowest per-
forming prediction out of the four disease states, suggest-
ing that much of the correlation may be a reflection of con-
founding variables such as age, sex, or usage of medications
like beta blockers. Nevertheless, a c-statistic of 0.74 from
consumer-grade wearables alone is a surprising and novel
finding.
Effect of Varying Amounts of Labeled Data
To quantify the impact of each pretraining technique, we
evaluated DeepHeart’s performance when trained on vary-
ing fractions of the labeled data (5%, 10%, 20%, 50%, 70%,
and 100%), using no pretraining, heuristic pretraining, and
semi-supervised sequence learning (Figure 4).
For hypertension and sleep apnea, unsupervised pretrain-
ing yields a 10x improvement in data-efficiency: the DNN
achieves nearly the same accuracy with 10% of labeled data
using unsupervised pretraining as it does with 100% of la-
beled data using no pretraining. For diabetes and cholesterol,
the effect is muted. For diabetes, this is due to a scarcity of
labels (1,678, vs 3,662-9,220 for the other conditions). For
high cholesterol, the lack of correlation between the number
of labels and accuracy of the algorithm likely confirms that
high cholesterol is primarily detected through the effect of
confounding variables such as age, sex, and medications.
Figure 3: ROC curves (sensitivity-specificity curves) com-
paring the accuracy of heuristic pretraining and semi-
supervised pretraining to the strongest overall baseline in
detecting diabetes, sleep apnea, high cholesterol, and high
blood pressure.
The shape of the ROC curves (Figure 3) are also inter-
esting to note. It is clear that the semi-supervised sequence
LSTM performs very well for detecting diabetes, sleep ap-
nea, and hypertension, three of the most highly prevalent
conditions with undiagnosis rates of 45.8%, 80%, and 20%
respectively. For high cholesterol, although the c-statistic is
lower, there are high-precision operating points which rule
out more than half of the study population. This suggests
wearables could be used to focus diagnostic testing on a
high-risk subset of the population, leading to cost-effective
screening for metabolic syndrome and getting at-risk pa-
tients care sooner.
Ablative Analysis of Input Channels
To determine the impact of each input channel, we tested
models using heart rate and step count in isolation.
Figure 4: Accuracy as a function of percentage of training la-
bels used for each condition. Sleep apnea and hypertension,
which show the greatest effect, have both a direct physiolog-
ical connection to heart rate variability and a large amount of
labeled data in our training set. For diabetes and high choles-
terol, the effect of adding more labeled data is muted due
to the low absolute number of labels and less direct physi-
ological connection, respectively. Error bars show the 95th
percentile confidence interval.
A model trained only on heart rate timeseries performed
significantly worse on diabetes and high blood pressure (de-
crease of 0.0653 and 0.0721 in AUC, respectively), and the
same on sleep apnea and high blood pressure (within the
95% confidence interval), suggesting that heart rate is be-
ing interpreted as a response to activity. Within the med-
ical literature, heart rate recovery after exercise is associ-
ated with lower risks of cardiovascular disease (Morshedi-
Meibodi et al. 2002). A model using only aggregate step
counts achieved an AUC of 0.7011 (diabetes), 0.5811 (sleep
apnea), 0.5714 (hbp), and 0.5601 (high cholesterol), sug-
gesting that although overall physical activity plays an im-
portant role in predicting the onset of disease, the heart’s
response to physical activity is a more salient biomarker that
can be captured using deep learning.
Discussion
We’ve shown that two methods, semi-supervised sequence
learning and heuristic pretraining, address a key technical
challenge in applying deep learning to medicine: achiev-
ing high accuracy with limited labeled data. Furthermore,
we’ve shown high accuracy at detecting four common health
conditions—diabetes, sleep apnea, hypertension, and high
cholesterol–using readily available, off-the-shelf heart rate
monitors. Since these four conditions are highly prevalent,
commonly undiagnosed, and reduced HRV is associated
with the earliest stages of disease progression (Schroeder
et al. 2005; Schroeder et al. 2003), this suggests a new ap-
proach to public health screening using deep learning.
While these results are promising, artificial intelligence-
based systems have shown high accuracy at medical tasks—
even outperforming human physicians—since the days of
MYCIN (Yu et al. 1979), CADUCEUS (Banks 1985), and
INTERNIST-I (Wolfram 1995). For AI-based systems to
broadly improve human health, several key challenges be-
yond prediction accuracy must be addressed.
A first challenge is confounding factors. Statistical mod-
els in medicine are typically used for etiology, not just pre-
diction, and cause (disease) and effect (treatment) may be in-
tertwined in subtle ways within medical data sets (Shmueli
and others 2010). For example, a person with previously-
diagnosed hypertension may be prescribed beta blockers,
which affect heart rate variability, and therefore an algorithm
with high prediction accuracy at identifying hypertension
may be picking up signals of both the underlying disease
and the treatment. While there are well-known algorithms to
adjust for confounders in linear models, confounder-aware
neural network architectures are a critical future area of re-
search.
A second challenge is deployment. While hospital depart-
ments such as the intensive care unit or radiology depart-
ment often have ample training data available, deploying a
new algorithm in a hospital is typically slow or impossible
because errors are costly (a severe error may cost a human
life), the technical implementation is cumbersome (an inte-
gration with an electronic medical record system), the orga-
nizational complexity is high (high regulatory burden, ne-
cessity to train physicians on new systems), and the finan-
cial incentives are often misaligned (for example, preventing
readmissions may reduce the hospital’s revenue). An alter-
native is to take an outside-in approach: design care path-
ways for ambulatory, mobile-based screening that operate
outside of the hospital but guide participants in to the ap-
propriate point of care when a neural network detects high
risk. Here, false negatives represent the status quo (no diag-
nosis), and with sufficiently high precision the cost of false
positives (e.g., blood tests, mobile ECGs) is exceeded by the
cost savings to the healthcare system of each true positive.
Since an algorithm can be packaged in a mobile app, it can
be updated and quickly deployed to participants. We are cur-
rently deploying our algorithm in ambulatory, mobile trials
in partnership with major medical centers to show real-world
efficacy and build a rigorous clinical evidence base (Tison et
al. 2017b).
A third challenge is interpretability. Deep learning sys-
tems perform well but are “black boxes,” whereas medical
systems prefer to provide an explanation of the chain of rea-
soning. We intend to incorporate mechanisms such as differ-
entiable attention (Xu et al. 2015; Chan et al. 2016) to help
both physicians and regulators understand the internal work-
ings of the neural network and its potential failure modes.
A last challenge is the time-scale and volume of data.
Many participants in our study have more than a year of
heart rate and step count data, corresponding to nearly
one million time steps. We intend to test neural architec-
tures that can better model long-range dependencies, such
as Clockwork RNNs (Koutnik et al. 2014), Phased LSTMs
(Neil, Pfeiffer, and Liu 2016), and Gaussian Process RNNs
(Joseph Futoma and O’Brien 2017) in order to better model
changes to a participant’s physiological state over a long pe-
riod of time.
While these challenges may seem daunting, the con-
straints of medicine—scarce labeled data, confounding
factors, difficulty of deployment, and the necessity of
interpretability—also represent opportunities to develop
new techniques. This work is a first step in showing how
health conditions can be detected using techniques first de-
veloped in natural language processing and computer vision.
Over time, we plan to extend this work to address the chal-
lenges above and deploy neural networks that can improve
health in the real world.
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Width Conv Depth LSTM Depth Initial Filter AF Diabetes High BP Apnea Chol Avg
32 2 2 12 0.7548 0.8709 0.8494 0.8610 0.8549 0.8382
32 2 2 5 0.7340 0.8724 0.8375 0.8594 0.8541 0.8315
32 2 4 12 0.7621 0.8748 0.8455 0.8664 0.8511 0.8400
32 2 4 5 0.7633 0.8659 0.7995 0.8567 0.8257 0.8222
32 4 2 12 0.7480 0.8540 0.8502 0.8583 0.8352 0.8291
32 4 2 5 0.7652 0.8622 0.8258 0.8592 0.8211 0.8267
32 4 4 12 0.7440 0.8711 0.8233 0.8605 0.8442 0.8286
32 4 4 5 0.7336 0.8628 0.8403 0.8626 0.8444 0.8287
64 2 2 12 0.7317 0.8696 0.8494 0.8599 0.8594 0.8340
64 2 2 5 0.7514 0.8719 0.8544 0.8585 0.8525 0.8377
64 2 4 12 0.7891 0.8647 0.8444 0.8597 0.8467 0.8409
64 4 2 12 0.7903 0.8517 0.8550 0.8622 0.8513 0.8421
64 4 2 5 0.7855 0.8655 0.8483 0.8559 0.8442 0.8399
64 4 4 12 0.8079 0.8805 0.8453 0.8584 0.8647 0.8514
64 4 4 5 0.7958 0.8756 0.8434 0.8632 0.8618 0.8480
128 2 2 5 0.7770 0.8653 0.8529 0.8607 0.8549 0.8422
128 2 4 12 0.8212 0.8718 0.8262 0.8604 0.8361 0.8431
128 2 4 5 0.7695 0.8727 0.8427 0.8630 0.8273 0.8350
128 4 2 12 0.8076 0.8668 0.8616 0.8613 0.8409 0.8476
128 4 2 5 0.7646 0.8658 0.8030 0.8516 0.8286 0.8227
128 4 4 12 0.8143 0.8723 0.8414 0.8600 0.8639 0.8504
128 4 4 5 0.7702 0.8640 0.8555 0.8575 0.8407 0.8376
Table 3: Hyperparameter tuning results, showing AUC ROC for each health condition, as well as the average across all health
conditions. Here, Width is the number of output channels in each convolutional and LSTM layer, Conv Depth is the number
of convolutional layers, LSTM Depth is the number of LSTM layers, and Initial Filter is the initial filter length of the first
convolutional layer.
